The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Incubator/Accelerator - II | Alive

Total Raised


About Kheiron Medical Technologies

Kheiron Medical Technologies is a healthcare software company. Through its Machine Learning technology, it seeks to makes cancer diagnoses faster, easier, cheaper and more accurate. Its Deep Learning algorithms analyze medical images and its software uses the analysis results to enable the automation of radiology reporting tasks.

Kheiron Medical Technologies Headquarter Location

2nd Floor, Stylus 116 Old St

London, England, EC1V 9BG,

United Kingdom

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Kheiron Medical Technologies

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Kheiron Medical Technologies in 1 CB Insights research brief, most recently on Sep 27, 2019.

Expert Collections containing Kheiron Medical Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Kheiron Medical Technologies is included in 6 Expert Collections, including Artificial Intelligence.


Artificial Intelligence

9,093 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.


Medical Devices

8,451 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.


Health Monitoring & Diagnostics

2,394 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Digital Health

13,084 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Health IT

7,900 items

Kheiron Medical Technologies Patents

Kheiron Medical Technologies has filed 9 patents.

The 3 most popular patent topics include:

  • Medical imaging
  • Breast cancer
  • Image processing
patents chart

Application Date

Grant Date


Related Topics




Artificial neural networks, Medical imaging, Image processing, Machine learning, Breast cancer


Application Date


Grant Date



Related Topics

Artificial neural networks, Medical imaging, Image processing, Machine learning, Breast cancer



Latest Kheiron Medical Technologies News

Artificial intelligence applications across the breast screening pathway

Dec 20, 2021

December 17, 2021 By Dr. Jonathan Nash New advances in artificial intelligence (AI) have potential to transform breast cancer screening and make the greatest impact when integrated across the entire screening pathway, not only during image interpretation. Along this pathway, two critical stages at which AI can dramatically improve outcomes are when women are invited to schedule their screening mammogram, especially considering screening backlogs exacerbated by COVID-19, as well as during the image acquisition and audit process. At the 2021 European Society of Breast Imaging (EUSOBI) Annual Scientific Meeting in October, Kheiron Medical Technologies, an applied science company focused on supporting breast cancer screening with machine-learning, presented a virtual workshop session covering this topic, titled “Showcasing the future of breast cancer screening: Applications of AI across the screening pathway.” The session featured presentations from leading experts, including renowned statistician Stephen Duffy, Professor of Cancer Screening, Barts and the London School of Medicine and Dentistry, Queen Mary University of London; Professor Ruud Pijnappel of the LRCB, the Dutch Expert Center for Breast Screening; and Dr. Randy Hicks of U.S.-based Regional Medical Imaging. Ad Statistics Quest Imaging Solutions provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs The panel was moderated by Mary Beth Chalk, patient advocacy advisor at Kheiron who is also a breast cancer survivor. She shared her experience and the life-changing importance of correct breast positioning and what artificial intelligence would have meant to her breast screening. Professor Duffy shared how the UK Breast Screening Programme is tackling the challenges of breast screening backlogs. Over the past 18-months, Covid-19 has exacerbated existing backlogs due to radiologist shortages and demanding workloads. As a result, there is more urgency than ever to ensure that millions of unscreened women around the world are not overlooked, especially those at greatest risk. Based on initial internal research, Kheiron’s AI-enabled invitation tool RSViP has been shown to flag higher risk women for screening. Earlier screening can contribute directly to significantly earlier detection rates, which in turn can lead to improved survivorship and a lower cost of care. To address the potential for AI integration during image acquisition and audit, Professor Pijnappel and Dr. Hicks discussed the importance of well-positioned, properly exposed mammograms. They shared lessons learned and the value they believe AI solutions such as Kheiron’s Mia IQ can bring to the acquisition of mammography images. Mia IQ is powered by artificial intelligence and machine learning to assess the image quality of mammograms and train radiographers to achieve proper breast positioning during mammography. Despite the success of the Mammography Quality Standards Act (MQSA) in improving and standardizing the quality of mammographic imaging, improper breast positioning remains the most common reason for technical failure under American College of Radiology clinical image quality review. Evidence suggests that technical issues are responsible for delays in diagnosing 22% of screen-detected cancers and 35% of interval breast cancers. In addressing the different stages of the breast screening pathway where AI can play a significant role in improving cancer detection and patient outcomes, the workshop underscored the potential for new solutions to make a positive impact on the future of breast screening. By adopting new AI-enabled technologies, breast radiologists and their teams will have the opportunity to give every woman, everywhere a better fighting chance against breast cancer. About the author: Dr. Jonathan Nash is the medical director at Kheiron Medical Technologies.

Kheiron Medical Technologies Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Kheiron Medical Technologies Rank

  • When was Kheiron Medical Technologies founded?

    Kheiron Medical Technologies was founded in 2016.

  • Where is Kheiron Medical Technologies's headquarters?

    Kheiron Medical Technologies's headquarters is located at 2nd Floor, Stylus, London.

  • What is Kheiron Medical Technologies's latest funding round?

    Kheiron Medical Technologies's latest funding round is Incubator/Accelerator - II.

  • How much did Kheiron Medical Technologies raise?

    Kheiron Medical Technologies raised a total of $22M.

  • Who are the investors of Kheiron Medical Technologies?

    Investors of Kheiron Medical Technologies include MedTech Innovator, Tech Nation, Greycroft, Connect Ventures, Hoxton Ventures and 9 more.

  • Who are Kheiron Medical Technologies's competitors?

    Competitors of Kheiron Medical Technologies include Koios Medical, Aidoc Medical,, Aidence, Ultromics and 13 more.

You May Also Like

Aidoc Medical

Aidoc finds and flags critical findings in medical images. By automatically prioritizing urgent, life-threatening conditions like intracranial hemorrhage and pulmonary embolism, Aidoc saves lives, improves patient care and cuts waiting time for the must urgent patients down to only a few minutes. The always-on AI integrates into a radiologist's workflow, reprioritizing cases without forcing radiologists to change the way they work. Aidoc was founded in 2016 and is based in Tel Aviv, Israel.

Ultromics Logo

Ultromics is a global health technology company that provides autonomous echocardiography analysis through AI solutions – empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease. Its cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

VoxelCloud Logo

VoxelCloud utilizes artificial intelligence and cloud-computing technologies to provide automated medical image analysis and clinical decision support for medical practitioners. VoxelCloud aims to provide accurate, accessible, and personalized medical image analysis by building medical image knowledge graph based on medical semantics and multiple artificial intelligence models.


Quibim, a company with its headquarters in Valencia, Spain, provides a whole-body medical imaging analysis. Quibim products are used worldwide by a huge diversity of research and care teams. Partners use Quibim Precision, a CE-marked whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy of treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers. Logo aims to use artificial intelligence and deep learning to automatically identify suspected LVOs (large vessel occlusion) on CTA imaging with the aim of alerting a patient's physician within minutes. The company was founded in 2016 and is based in San Francisco, California.

Infervision Logo

Infervision is a global high-tech enterprise in medical artificial intelligence, aiming to empower doctors with higher efficiency and benefit patients with better diagnosis, outcome, and lower cost. Infervision provides products and services to providers, and patients; with robust A.I. solutions fully integrated with the healthcare workflow to help diagnosing various diseases and conditions such as cerebral hemorrhage, lung cancer, bone fractures, emphysema, and more. Infervision also provides an AI-powered research platform for medical professionals with any research directions and needs.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.